Target intelligence / Profile preview

Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2)

Target
BAIAP2
Molecular classification
Adapter protein, Scaffold protein, BAR/IMD domain-containing protein, Cytoskeletal anchor, Rho-GTPase signaling effector
01

Overview

Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2), also known as IRSp53, is a multifunctional adaptor protein that acts as a central integrator of membrane curvature, actin cytoskeleton remodeling, and Rho-family GTPase signaling[1][4]. It contains a conserved N-terminal IMD (IRSp53/MIM homology) domain that binds and deforms cellular membranes, facilitating the formation of filopodia and lamellipodia in motile cells[1]. The C-terminal SH3 domain enables recruitment of actin regulatory proteins (such as Mena, Eps8, WASF family, and Arp2/3 complex), allowing BAIAP2 to spatially and temporally regulate actin assembly in coordination with Rac1 and Cdc42 pathways[1][4]. BAIAP2 is pivotal for cell migration, invasion, and neuronal morphogenesis, with critical roles in growth cone guidance, synaptic structure, and developmental patterning. Disease associations include its fusion with FGFR3 in some bladder cancers generating oncogenic signals, and its interaction with the DRPLA gene implicated in autosomal dominant neurodegenerative disorders[1][4]. It is also exploited by certain pathogens to modulate host cytoskeletal architecture[1]. The dynamic coordination of membrane deformation and actin remodeling by BAIAP2/IRSp53 underscores its importance in both physiological and pathological cellular processes.

Other names
IRSp53IRS-58BAI-associated protein 2BAP2Fas ligand-associated factor 3 (FLAF3)WASP and MIM like (WAML)Insulin receptor substrate p53Insulin receptor substrate p53/p58Insulin receptor substrate protein of 53 kDaInsulin receptor substrate of 53 kDaBAI1-associated protein 2Protein BAP2Brain-specific angiogenesis inhibitor 1-associated protein 2IRSp53/58IRSP53
02

Biological functions

Regulation of actin cytoskeletonMembrane remodeling and curvature sensingCell migration and invasionFormation of filopodia and lamellipodiaNeurite growth and guidanceSynaptic architecture and plasticityInsulin signaling
03

Disease associations

Neurodegenerative disease (e.g., Dentatorubral-pallidoluysian atrophy)Cancer (e.g., FGFR3-BAIAP2 fusion in bladder cancer)Pathogen interaction (e.g., exploited by Escherichia coli for actin pedestal formation)Wiskott-Aldrich syndrome (implicated through cytoskeletal regulation)

Beyond the preview

Go deeper on Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call